394 related articles for article (PubMed ID: 36157452)
1. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
Zhang W; Yang Z; Zhou F; Wei Y; Ma X
Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
[TBL] [Abstract][Full Text] [Related]
2. Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of
Wu WY; Jiao X; Song WX; Wu P; Xiao PQ; Huang XF; Wang K; Zhan SF
Front Endocrinol (Lausanne); 2023; 14():1187882. PubMed ID: 37347115
[TBL] [Abstract][Full Text] [Related]
3. Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses.
Zhang K; Wang K; Zhang C; Teng X; Li D; Chen M
BMC Cancer; 2022 Jun; 22(1):687. PubMed ID: 35733175
[TBL] [Abstract][Full Text] [Related]
4. Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation.
Liu X; Ren Y; Qin S; Yang Z
BMC Complement Med Ther; 2024 May; 24(1):202. PubMed ID: 38783288
[TBL] [Abstract][Full Text] [Related]
5. Molecular and metabolic mechanisms of bufalin against lung adenocarcinoma: New and comprehensive evidences from network pharmacology, metabolomics and molecular biology experiment.
Shi S; Zhao S; Tian X; Liu F; Lu X; Zang H; Li F; Xiang L; Li L; Jiang S
Comput Biol Med; 2023 May; 157():106777. PubMed ID: 36924737
[TBL] [Abstract][Full Text] [Related]
6. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
Li JL; Hou W
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253
[TBL] [Abstract][Full Text] [Related]
7. Genetic Surveillance of SARS-CoV-2 M
Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
[TBL] [Abstract][Full Text] [Related]
8. Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma.
Zeng Y; Pan Y; Zhang B; Luo Y; Tian J; Wang Y; Ju X; Wu J; Li Y
Med Sci Monit; 2022 Jul; 28():e937131. PubMed ID: 35871777
[TBL] [Abstract][Full Text] [Related]
9. Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment - California, December 2021-May 2022.
Malden DE; Hong V; Lewin BJ; Ackerson BK; Lipsitch M; Lewnard JA; Tartof SY
MMWR Morb Mortal Wkly Rep; 2022 Jun; 71(25):830-833. PubMed ID: 35737591
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics approach to identify common gene signatures of patients with coronavirus 2019 and lung adenocarcinoma.
Liang X; Chen Y; Fan Y
Environ Sci Pollut Res Int; 2022 Mar; 29(15):22012-22030. PubMed ID: 34775559
[TBL] [Abstract][Full Text] [Related]
11. Public Health Impact of Paxlovid as Treatment for COVID-19, United States.
Bai Y; Du Z; Wang L; Lau EHY; Fung IC; Holme P; Cowling BJ; Galvani AP; Krug RM; Meyers LA
Emerg Infect Dis; 2024 Feb; 30(2):262-269. PubMed ID: 38181800
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of Paxlovid against COVID-19 is the result of the tight molecular docking between M
Dawood AA
Adv Med Sci; 2023 Mar; 68(1):1-9. PubMed ID: 36368287
[TBL] [Abstract][Full Text] [Related]
13. Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles.
Uddin MN; Akter R; Li M; Abdelrahman Z
Chem Biol Interact; 2021 Feb; 335():109370. PubMed ID: 33422520
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis.
Wen W; Chen C; Tang J; Wang C; Zhou M; Cheng Y; Zhou X; Wu Q; Zhang X; Feng Z; Wang M; Mao Q
Ann Med; 2022 Dec; 54(1):516-523. PubMed ID: 35118917
[TBL] [Abstract][Full Text] [Related]
15. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL
Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448
[TBL] [Abstract][Full Text] [Related]
16. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
17. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
Ni KW; Sun GZ
Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Potential Mechanism of Action of Ursolic Acid against Gastric Cancer and COVID-19 using Network Pharmacology and Bioinformatics Analysis.
Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
Curr Pharm Des; 2023; 29(16):1274-1292. PubMed ID: 37218202
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 induces "cytokine storm" hyperinflammatory responses in RA patients through pyroptosis.
Zheng Q; Lin R; Chen Y; Lv Q; Zhang J; Zhai J; Xu W; Wang W
Front Immunol; 2022; 13():1058884. PubMed ID: 36532040
[TBL] [Abstract][Full Text] [Related]
20. Network pharmacology and experimental validation identify the potential mechanism of sophocarpine for COVID-19.
Zhang HX; Zhang X
J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35622496
[No Abstract] [Full Text] [Related]
[Next] [New Search]
